14.5%) at 1400 g and 25 ℃, for 22 minutes, which produced a KC-enriched fraction in the middle whitish layer. Purification was achieved by allowing the cells to adhere to plastic culture plates at 37 ℃ for 20 minutes, and nonadherent cells were removed by washing, as previously reported [2] . For activated HSCs, cells were maintained in DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic (cat. 15420-062.
Gibco, NY, USA) for 7 days. Kupffer cells were maintained in RPMI 1640 medium supplemented with 10% FBS and 1% antibiotic-antimycotic. LSECs were purified by MACS using anti-CD146 (cat. 130-092-007, Miltenyi Biotec, German) and anti-CD11b MACS beads. CD146 + and CD11b -cells were used as previously described [3] . Primary hepatocytes were obtained by collagenase perfusion, followed by Percoll (cat. 14051ES60, Yeasen, Shanghai, China) density gradient centrifugation, as previously described [4] . Isolated hepatocytes were plated on rat collagen type I (cat. 354236, Coring, MA, USA)-coated dishes and maintained in Media 199 cell culture medium supplemented with 10% FBS and 1% antibiotic-antimycotic. A subset of cells was harvested after 24 hours and served as the quiescent control cells. All HSC cells were treated as indicated and harvested after 3-7 days, as indicated.
Peripheral blood mononuclear cell (PBMCs) from human (cat. GS3701) and mice (GS3702, Genview, Shanghai, China) were assessed using respective commercial kit.
Measurement of serum GDNF concentration
A human GDNF ELISA kit (cat. DY212) from R&D (MN, USA) was used. A mouse GDNF ELISA kit was purchased from Boster Biological Technology Co. Ltd (EK0935, Wuhan, China). 96-well microplates (R&D, cat. DY990) were coated with a capture antibody. After washing with wash buffer and blocking for 1 hour with reagent diluent, the samples were added and incubated for 2 hours at 37 °C. The detection antibody was added and incubated for 1 hour at 37 °C. Working streptavidin-HRP was then added for 20 minutes at 37°C. Substrate solution was added for 20 minutes at 37 °C, and stop solution (2N H2SO4) was then added. The optical density was read at 450 nm using Varioscanlux (Thermo, MN, US).
Mice
Male C57/BL6 mice (18-20 g) were housed in an air-conditioned room at 25 ℃ with a 12 hour-dark/light cycle. Mice received humane care with unlimited access to a chow diet and water during the study. All of the study protocols complies with the current ethical considerations of Putuo Hospital, Shanghai University of Traditional Chinese Medicine's and HwaMei Hospital, University of Chinese Academy of Sciences Animal Ethic Committees. All animal procedures were conducted in accordance with Chinese laws and with the approval of the home office and local ethics committees.
For CCl4-induced liver fibrosis, mice received three weekly intraperitoneal CCl4 injections (0.25 ml/kg) for 6 weeks to induce chronic liver injury and were then sacrificed 2 days after the last injection. Olive oil was used as the vehicle control.
For the bile duct ligation (BDL) model, mice were anesthetized by the injection of ketamine and xylazine. After midline laparotomy, the common bile duct was ligated twice with 6-0 silk sutures, and the abdomen was closed. The sham operation was performed similarly, except that the bile duct was not ligated. After two weeks of sham and BDL operation, the mice were sacrificed and tissue and blood samples were harvested.
For the diet-induced NASH fibrosis model, mice were fed HFD (60% of calorie from fat, cat. D12492i, Research Diets, New Brunswick) for 14 weeks [5] or a methionineand choline-deficient-diet (MCD) (cat. TP3006, Trophic, Nantong, China) for 8 weeks [6] .
Ad-GDNF-virus and Ad-sgGDNF-virus injections.
Recombinant adenoviruses (10 6 pfu/ml each) comprising Gdnf sgRNA CRISPR adenovirus (cat. K4921721), scrambled sgRNA CRISPR adenovirus (cat. K020), Cas9 nuclease adenovirus (cat. K004), GDNF-His (cat. 093692A), and Adeno CMV Null (cat. 000047A) were purchased from Abm (Richmond, Canada). We amplified the adenoviruses in HEK293 cells, which were then centrifuged in a Sorvall LYNX 4,000 superspeed centrifuge (Thermo Scientific). Upon collection, the adenovirus preparations were desalted using PD-10 spin adapter columns (cat. 28-9262-94, GE Healthcare, UK) and stored at 10 11 pfu/ml in HBSS.
Male C57BL/6 mice were i.p. injected with olive oil or CCl4 three times a week for 6 weeks. Adenovirus injections (1×10 11 pfu in 0.2 ml HBS per mouse) were performed via the tail vein at the end of the first, third, and fifth weekends [7] . In the BDL model, male C57BL/6 mice were injected as described above at 1 week after the sham-or BDL-operation, and the mice were sacrificed 1 week later.
CCl4 mice (n=18) were randomly divided into the CCl4-control Ab (IgG, Proteintech, cat. B900610), CCl4-Ab1 (Abcam, cat. 18956), and CCl4-Ab2 (Santa Cruz, cat.
sc-13147) groups from the beginning of the second week of CCl4 treatment. Three groups continued to receive weekly CCl4 treatment in addition to the administration of either 50 μl of IgG, Ab1 or Ab2 (once a week, in total 3 times), which was administered i.p. at a dose of 400 ng/g BW dissolved in physiological saline [8] . At the end of the fourth week, all animals were sacrificed.
Measurement of serum ALT and AST concentrations. Mouse serum ALT and AST
concentrations were determined by a Varioskan LUX (Thermo, CA) and using ALT and AST assay kit that were purchased from Jiangcheng (Nanjing, China).
Sirius red staining and quantification
Liver specimens were preserved in 4% paraformaldehyde and then dehydrated in a graded alcohol series. Then, the sections were embedded in paraffin blocks, cut into 5-μm-thick sections and placed on glass slides. The sections were stained with Sirius 
Immunohistochemical staining and quantification
After deparaffinization and dehydration, antigen retrieval was performed using microwave for 5 minutes before peroxidase quenching with 3% H2O2 in phosphate-buffered saline (PBS) for 15 minutes. Subsequently, the sections were blocked with 5% bovine serum albumin (BSA) for 30 minutes and then incubated with a primary antibody at a dilution ratio of 1:500 in PBS overnight at 4 ℃. The negative control was treated the same as the sample groups, except that primary antibodies were omitted in the incubation steps. The percentage of the area of the section occupied by positive staining using IPP software.
For double immunohistochemical staining, frozen sections were fixed in 1% paraformaldehyde (PFA) for 10 minutes and then washed 3 times with PBS. Sections were postfixed in precooled ethanol/acetone 2:1 for 5 minutes, washed 3 times with PBS washed and incubated in 5% BSA blocking solution for 30 minutes. Primary antibodies were added to the slides for 1 hour, and 1 drop of rabbit AP polymer and mouse HRP polymer was applied to the sections. Next, steps are DAB staining and 3 washes with PBST were performed, followed by incubation in permanent red working solution for 20 minutes, mounting and analysis.
qPCR analysis
Total RNA was extracted using Trizol (Takara, Japan), followed by the reverse transcription of total RNA to cDNA with a PrimeScript RT reagents kit (perfect real time) from Takara (Shanghai, China). Subsequently, cDNA was subjected to quantitative real-time polymerase chain reaction (PCR) with the ABI ViiA™ 7Dx real-time PCR system (Life Technologies, NY, USA). The levels of the target mRNAs were normalized to that of 18S rRNA. The gene expression values are expressed as 2-ΔCt. PCR primer sequences were provided by Sangon (Shanghai, China) and are as presented in Supporting Table 1 .
Immunoblotting
Liver and cell lysates were prepared with ice-cold radioimmune precipitation assay buffer containing protease inhibitors. After protein quantification, the protein lysates were subjected to polyacrylamide gel electrophoresis and transferred onto Immobilon-P transfer membranes, which were then blocked and exposed to the corresponding antibodies. The blots were visualized by enhanced chemiluminescence (GE Healthcare Life Sciences) and digital images and densitometry were performed using a Bio-Rad system.
Cytoplasmic and nuclear protein extraction
The cells were washed twice followed by the addition of lysis buffer A (10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 0.1 mM EDTA (pH 8.0)). Then, the cells were collected and centrifuged at 4 ℃ 5000 rpm for 5 minutes, and the supernatant was transferred as the cytoplasmic protein extract. To the remaining pellets was added lysis buffer C (50 mM HEPES-KOH (pH 7.8), 20% glycerol, 420 mM KCl, 0.1 mM EDTA (pH 8.0), 5 mM MgCl2) followed by mixing, vortexing, and incubation on ice for 30 minutes and centrifugation at 4 ℃ and 14000 rpm for 10 minutes. Finally, the supernatants were transferred to a new tube as the nuclear protein extracts.
Molecular Docking
The crystal structure of the ALK5 extracellular region was obtained from the Protein Data Bank (PDB ID:2L5S), and GDNF structure was obtained from 3FUB. Prior to docking, the structures were both prepared with the built-in Molecular Operating Environment (MOE, Canada) method. The ALK5-GDNF complex model was constructed by the protein-protein docking method, as described previously [9] .
Briefly, of ALK5 and GDNF complex was generated by rigid-body docking using PatchDock (http://bioinfo3d.cs.tau.ac.il/PatchDock/). Based on the shape complementarity of the soft molecular surface, PatchDock was used to determine the best starting candidate solutions. The PatchDock algorithm divided the Connolly dot surface representation of the proteins into convex, concave, and flat patches.
Complementary patches were matched to generate candidate solutions. According to both geometric fit and atomic desolvation energy, the scoring function was utilized to evaluate each candidate solution. The best docked candidate solutions were re-evaluated by FireDock (http://bioinfo3d.cs.tau.ac.il/FireDock/), on the basis of global energy, attraction van der Waals energy, repulsive van der Waals energy, atomic contact energy, insideness measurements, Coulomb electrostatics, and hydrogen and disulfide bonds. By restricting the side chains in interaction interface to small rigid-body movements, FireDock optimized and rescored candidate solutions and then produced the top solution of the complex structure. Molecular graphics for the best binding pose were generated using PyMOL (DeLano Scientific, http://www.pymol.org) and LigPlus.
Mutagenesis
The pcDNA3-ALK5 wild-type plasmid was purchased from Addgene (cat. 80876).
The interaction of ALK5 and GDNF occurs mainly through His 
Co-immunoprecipitation
For ALK5 and GDNF immunoprecipitation, we followed the Co-IP protocol as described previously [12, 13] . Cells were lysed with 1 ml lysis buffer containing protease inhibitors for 10 minutes at 4 ℃. After centrifugation at 12000 rpm for 15 minutes, the protein concentrations were measured, and equal amounts of lysate were used for immunoprecipitation. Immunoprecipitation was performed with different antibodies and protein A-Sepharose (GE Healthcare Bio-Sciences AB) for 1 hour at 4℃. Thereafter, the precipitants were washed three times, and the immune complexes were eluted with sample buffer for 5 minutes at 95 ℃. The immunoprecipitated proteins were then separated by SDS-PAGE.
Laser Confocal Microscopy
Tri-color immunofluorescence staining of human liver sections was performed with different antibody combinations as detailed in our previous report [2] . For instance, for GDNF, ALK5, and α-SMA tri-color staining, liver sections were first incubated with rabbit anti-GDNF for 1 hour at 37 ℃, then with Cy2-conjugated goat anti rabbit 
Supporting Discussion

GDNF -a trophic factor in neural cells
GDNF was originally identified based on its ability to maintain embryonic ventral midbrain dopaminergic neuron survival in vitro [14] . Mice with a disrupted GDNF gene display defects in primary sensory, sympathetic and motor neurons and die shortly after birth due to the absence of renal function [15] . Other studies have described protective effects of GDNF in animal models of Parkinson's disease [16] , and GDNF-transduced MSCs are protective against inflammation-induced Parkinsonism [17] . Subsequently, gene therapy or cell therapy with GDNF gene-transduced BMSCs has improved the recovery process in a rat model of spinal cord injury [18] . These data indicate a protective role for GDNF in neural physiology.
Furthermore, GDNF injection into the ventral tegmental area, a dopaminergic brain region important for addiction, inhibits certain biochemical adaptations to cocaine or morphine [19] , and clinical studies show that GDNF levels are increased in the parietal cortex and plasma of patients with depressive disorder [20] . In addition to its neuronal functions, increased GDNF levels have been reported following exposure to cytotoxic agents, including radiation [21] , and in cancer cells as a pro-angiogenic factor [22] .
Supporting Tables   S-Table 1 
S-Table 2. NAFLD patient characteristics
The data are expressed as the mean ± standard deviation. 
